248 related articles for article (PubMed ID: 28546001)
1. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
Wang H; Xu W
Biochem Biophys Res Commun; 2017 Jul; 489(1):1-7. PubMed ID: 28546001
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L
Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662
[TBL] [Abstract][Full Text] [Related]
3. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
4. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.
Qin QP; Wang ZF; Huang XL; Tan MX; Zou BQ; Liang H
Eur J Med Chem; 2019 Dec; 184():111751. PubMed ID: 31593828
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
6. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
Hu Q; Gao M; Feng G; Liu B
Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
9. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
12. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.
Cai G; Yu W; Song D; Zhang W; Guo J; Zhu J; Ren Y; Kong L
Eur J Med Chem; 2019 Jul; 174():236-251. PubMed ID: 31048139
[TBL] [Abstract][Full Text] [Related]
13. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
Lv N; Sun M; Liu C; Li J
Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiproliferative activities, and DNA binding of coumarin-3-formamido derivatives.
Shi J; Lu W; Chen J; Sun L; Yang S; Zhou M; Xu L; Ma Y; Yu L
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000236. PubMed ID: 33079446
[TBL] [Abstract][Full Text] [Related]
16. Ferulenol, a Sesquiterpene Coumarin, Induce Apoptosis via Mitochondrial Dysregulation in Lung Cancer Induced by Benzo[a]pyrene: Involvement of Bcl2 Protein.
Lariche N; Lahouel M; Benguedouar L; Zellagui A
Anticancer Agents Med Chem; 2017; 17(10):1357-1362. PubMed ID: 28270083
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
Ji H; Tan Y; Gan N; Zhang J; Li S; Zheng X; Wang Z; Yi W
Bioorg Med Chem; 2021 Jan; 29():115870. PubMed ID: 33221062
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
20. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
Emami S; Dadashpour S
Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
